Artera, a company that utilizes AI for patient communications, made the announcement while revealing it has achieved $100 million in annual revenue. Its products use AI for follow-ups after patient care, in addition to supporting clinical decisions.

According to data presented at RSNA, the capacity to expand prgrams exists, but the funds do not.

When fillers are injected without imaging guidance, there is a risk that the materials could be misplaced. A common complication of this scenario is vascular occlusion, which occurs when filler is injected in a way that disrupts bloodflow to arteries. 

Hemostemix believes its new cell therapy platform can help treat peripheral artery disease, congestive heart failure, cardiomyopathy and other serious medical conditions. The company plans on scooping up multiple practices to conduct additional research and increase the use of its platform. 

There is a risk of certain pericardial patches not being as strong or durable as needed. Customers are urged to identify, quarantine and replace these devices.

Eric Cordes, MD, 63, of Simi Valley, California, was a highly respected diagnostic specialist with Adventist Health Simi Valley and Focus Medical Imaging. 

A consultant at the VA White River Junction Healthcare System in Vermont, Klein is a noted expert in the diagnosis and staging of lung cancer. 

The Raleigh, North Carolina-based company—previously known as US Radiology Specialists—hopes to raise as much as $500 million through the IPO,